Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.995    -0.215 (-9.73%)
Bid:
1.905
Ask:
2.19
Spread: 0.285 (14.961%)
Market Cap: £40.02m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Disposal

9 Aug 2010 07:00

RNS Number : 7228Q
Quintain Estates & Development PLC
09 August 2010
Β 

ο»Ώ

Β 

9 August 2010

Β 

Quintain Estates & Development plc

("Quintain" / "Company" / "Group")

Β 

Greenwich Peninsula's Pier Walk Sold at 5.9% Yield

Sale price 6% above latest valuation

Β 

Quintain Estates and Development plc announces the sale of Pier Walk at Greenwich Peninsula to Deka Immobilien GmbH, a subsidiary company of the DekaBank Group, Germany's largest manager of open-ended property funds. The retail units within the building will be leased back to the joint venture between Quintain and Lend Lease (Europe) Ltd, Greenwich Peninsula Regeneration Ltd ("GPRL"), at no cost for 125 years.

Β 

The sale price for the building of Β£97.1m was settled by a cash payment and represents an uplift of 6% on the latest independent valuation (31 March 2010) and a yield of 5.9%. The offices were pre-let on a 20 year lease to Transport for London, which took occupation in August last year and now accommodates 1,800 of its employees within the building. Quintain and Lend Lease each held a 50% interest in the asset, which they jointly developed and let.

Β 

This disposal is in line with Quintain's funding strategy for its Urban Regeneration business, whereby assets are sold once value has been created from them, and the proceeds re-invested into alternative opportunities with higher potential for value creation.

Β 

Under the terms of the deal GPRL retains control of the seven retail units on the ground floor of the building, five of which are under offer to major retailers and restaurant brands, enabling the company to progressively build the retail brand of this emerging destination.

Β 

Adrian Wyatt, Chief Executive of Quintain, comments:

Β 

"This sale achieves three things for Quintain: It fulfils one of our key milestones for the financial year, which together are designed to move the Company substantially closer to the achievement of our 2013 business plan; it demonstrates in a difficult market the strength of the independent valuation of our assets at Greenwich Peninsula; and, finally, it enables us to realise the value we have created within the asset and recycle resources into other opportunities with potential for higher returns."

Β 

For further information, please contact:

Β 

Quintain Estates & Development plc

Rebecca Worthington / Cressida Curtis

Tel: +44 (0) 20 7495 8968

Β 

Financial Dynamics

Stephanie Highett / Dido Laurimore / Laurence Jones

Tel: +44 (0) 20 7831 3113

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
DISLLFVRTVIRIII
Date   Source Headline
1st Aug 20247:00 amRNSValkor Project Update
10th Jul 20247:00 amRNSMarine Project Update
26th Jun 20247:00 amRNSExtended agreement with BTG Bioliquids for bioMSAR
29th May 20247:00 amRNSRepresentation Agreement Addendum & Warrants Grant
28th May 20247:00 amRNSOCP Commercial Framework Agreement
2nd May 20247:00 amRNSQuadrise-Vertoro JDA to sea-trial bioMSAR Zero
29th Apr 20247:00 amRNSMarine Project Update
19th Apr 20247:00 amRNSValkor Project Update
12th Apr 20244:58 pmRNSResults of Open Offer
22nd Mar 20243:10 pmRNSExtension of Open Offer Closing Date
20th Mar 20241:01 pmRNSInvestor Presentation
19th Mar 20247:00 amRNSPlacing Results, Open Offer & Posting of Circular
18th Mar 20244:55 pmRNSProposed Placing, Subscription and Open Offer
18th Mar 20244:53 pmRNSInterim Results
15th Feb 20247:00 amRNSAgreement with Euthenia & BTG Bioliquids
6th Feb 20247:00 amRNSMarine Project Update
6th Dec 20237:00 amRNSUpdate re bioMSARâ„¢ and bioMSARâ„¢ Zero Development
27th Nov 20235:46 pmRNSResult of AGM
27th Nov 20237:00 amRNSAGM Statement
22nd Nov 20237:00 amRNSMorocco Project Update
9th Nov 20237:00 amRNSPublication of 2023 Sustainability Report
31st Oct 202312:45 pmRNSMorocco Project Update
27th Oct 20234:20 pmRNSPosting of Annual Report & Notice of AGM
24th Oct 20239:33 amRNSChange of Nominated Adviser
2nd Oct 20237:30 amRNSDirectorate Change
2nd Oct 20237:00 amRNSFinal Results and Notice of AGM
12th Sep 20237:00 amRNSMorocco Project Update
29th Aug 20237:00 amRNSValkor Project Update
24th Aug 202312:29 pmRNSValkor Update
18th Aug 20233:46 pmRNSMorocco Update
4th Aug 20237:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 20234:15 pmRNSDirector/PDMR Shareholding
28th Jul 20234:25 pmRNSDirector/PDMR Shareholding
25th Jul 20233:34 pmRNSResults of Open Offer
7th Jul 202312:00 pmRNSInvestor Presentation
7th Jul 202310:38 amRNSPlacing Results, Open Offer & Posting of Circular
7th Jul 20237:00 amRNSProposed Placing and Open Offer
22nd Jun 20237:00 amRNSMorocco Update
12th Jun 20237:00 amRNSValkor Site License & Supply Agreement
8th Jun 20237:00 amRNSJoint Development Agreement with BTG Bioliquids
26th May 20237:00 amRNSVertoro Joint Development Agreement Update
22nd May 20237:00 amRNSMorocco Update
16th May 20234:29 pmRNSReplacement: Business Update
16th May 20237:00 amRNSBusiness Update
25th Apr 20237:00 amRNSAppointment of Joint Broker
29th Mar 20237:00 amRNSInterim Results
28th Mar 20237:00 amRNSChange of Company Name
22nd Oct 20155:26 pmRNSDelisting of Quintain ordinary shares
15th Oct 20154:30 pmRNSHolding(s) in Company
15th Oct 20154:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.